These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 11279623

  • 21. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG.
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [Abstract] [Full Text] [Related]

  • 22. The experience of Flebogammadif® in primary immune thrombocytopenia.
    Julia A.
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):12-5. PubMed ID: 21466547
    [Abstract] [Full Text] [Related]

  • 23. Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura.
    Shirota T, Yamamoto H, Fujimoto H, Harada Y, Okada K, Uchida H, Roppongi H, Hayashi T.
    Am J Hematol; 1997 Dec; 56(4):272-6. PubMed ID: 9395191
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis.
    Ghalib R, Levine C, Hassan M, McClelland T, Goss J, Stribling R, Seu P, Patt YZ.
    Hepatology; 2003 May; 37(5):1165-71. PubMed ID: 12717398
    [Abstract] [Full Text] [Related]

  • 26. [Curative effect of interleukin 11 on chronic idiopathic thrombocytopenic purpura].
    Zhang QR, Wu DP, Chen LS, Cao RN.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):176-8. PubMed ID: 16584619
    [Abstract] [Full Text] [Related]

  • 27. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
    Zhao YQ, Wang QY, Zhai M, Xu J, Chen XQ, Liu WL, Zhang M, Song SJ, Wang JM, Meng FY, Shan YD.
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668
    [Abstract] [Full Text] [Related]

  • 28. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
    Duperier T, Brody F, Felsher J, Walsh RM, Rosen M, Ponsky J.
    Arch Surg; 2004 Jan; 139(1):61-6; discussion 66. PubMed ID: 14718278
    [Abstract] [Full Text] [Related]

  • 29. Anti-D treatment for chronic immune thrombocytopenic purpura: clinical and laboratory aspects.
    Sagripanti A, Ferretti A, Giannessi D, Carpi A, Bernini W, Ambrogi F, De Caterina R.
    Biomed Pharmacother; 1998 Jan; 52(7-8):293-7. PubMed ID: 9809171
    [Abstract] [Full Text] [Related]

  • 30. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD, Herrington JD.
    Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
    [Abstract] [Full Text] [Related]

  • 31. Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura.
    McMillan R.
    Blood Rev; 2002 Mar; 16(1):51-5. PubMed ID: 11913996
    [Abstract] [Full Text] [Related]

  • 32. The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital.
    Marquínez-Alonso I, Escudero-Vilaplana V, Pernía S, Beléndez Bieler C, Fernández-Llamazares CM, Sanjurjo-Sáez M.
    J Clin Pharm Ther; 2014 Aug; 39(4):376-82. PubMed ID: 24702274
    [Abstract] [Full Text] [Related]

  • 33. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP.
    Acta Paediatr Taiwan; 2006 Aug; 47(5):226-31. PubMed ID: 17352309
    [Abstract] [Full Text] [Related]

  • 34. Low dose intravenous immunoglobulin for acute immune thrombocytopenic purpura in children.
    Nuchprayoon I, Seksarn P, Vanichsetakul P, O-chareon R.
    Asian Pac J Allergy Immunol; 2001 Mar; 19(1):11-6. PubMed ID: 11495294
    [Abstract] [Full Text] [Related]

  • 35. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
    Aleem A.
    Platelets; 2011 Mar; 22(1):1-7. PubMed ID: 20964585
    [Abstract] [Full Text] [Related]

  • 36. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.
    Colovic M, Dimitrijevic M, Sonnenburg C, Suvajdzic N, Donfrid M, Bogdanovic A.
    Hematol J; 2003 Mar; 4(5):358-62. PubMed ID: 14502262
    [Abstract] [Full Text] [Related]

  • 37. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN, Kozuch P, Varma M.
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [Abstract] [Full Text] [Related]

  • 38. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates.
    Schlerman FJ, Bree AG, Kaviani MD, Nagle SL, Donnelly LH, Mason LE, Schaub RG, Grupp SA, Goldman SJ.
    Stem Cells; 1996 Sep; 14(5):517-32. PubMed ID: 8888493
    [Abstract] [Full Text] [Related]

  • 39. Thrombopoietic activity of recombinant human interleukin-11 in nonhuman primates with ACNU-induced thrombocytopenia.
    Saitoh M, Taguchi K, Yasuda S, Kikumori M, Nishimori T, Suda M, Okamiya H, Usuda S, Miyata K.
    J Interferon Cytokine Res; 2000 Jun; 20(6):539-45. PubMed ID: 10888110
    [Abstract] [Full Text] [Related]

  • 40. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD, Fogarty PF, Shah P, Brainsky A.
    Platelets; 2015 Jun; 26(1):93-6. PubMed ID: 24433306
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.